...
【24h】

Opsoclonus as a manifestation of Hashimoto's encephalopathy

机译:桥骨性脑病的表现

获取原文
获取原文并翻译 | 示例
           

摘要

We present a 59-year-old male with early manifestation of opsoclonus associated with gait ataxia as a rare clinical presentation of Hashimoto's encephalopathy. Empiric use of intravenous immunoglobulin followed by intravenous high dose methylprednisolone was initiated with subsequent remittance of opsoclonus, encephalopathy, ataxia, and tremor. Extensive workup for infectious, autoimmune, and paraneoplastic etiologies were undertaken and all studies were negative. Thyroglobulin antibodies (312 U/mL) and thyroid peroxidase antibodies (457 U/mL) were elevated (normal <60 U/mL) with a euthyroid state (thyroid stimulating hormone 3.13 μIU/mL). Three months after intravenous steroid therapy, the concentrations of thyroglobulin and thyroid peroxidase antibodies were retested and found to have decreased considerably. Thus, with steroid therapy, the patient's opsoclonus and encephalopathy improved. We have presented a patient with a rare case of opsoclonus as the principal presenting feature of Hashimoto's encephalopathy that was incompletely responsive to intravenous immunoglobulin and resolved with corticosteroids. This report underscores the importance for clinical practitioners to maintain a high index of suspicion for Hashimoto's encephalopathy in cases of opsoclonus, especially when accompanied by an atypical presentation.
机译:我们提出了一个59岁的男性,伴有步态共济失调的早期表现,是桥本脑病的罕见临床表现。经验性使用静脉注射免疫球蛋白,然后静脉注射大剂量甲基强的松龙,随后出现汇兑渗透,脑病,共济失调和震颤。进行了广泛的感染性,自身免疫性和副肿瘤病因检查,所有研究均为阴性。甲状腺球蛋白抗体(312 U / mL)和甲状腺过氧化物酶抗体(457 U / mL)升高(正常<60 U / mL),处于甲状腺正常状态(甲状腺刺激激素3.13μIU/ mL)。静脉类固醇治疗后三个月,再次检测了甲状腺球蛋白和甲状腺过氧化物酶抗体的浓度,发现它们的浓度已大大降低。因此,通过类固醇疗法,患者的视疲劳和脑病得以改善。我们已经介绍了一个病人,它是对桥本脑病的主要表现特征,该病人患有视骨膜炎的罕见病例,该病对静脉内免疫球蛋白的反应不完全,可以用皮质类固醇解决。该报告强调了对于临床医生在视疲劳时,尤其是在伴有非典型表现时,保持高度怀疑桥本脑病的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号